Get the Stockscreener App
87.62
1.34%
1.19
After Hours:
87.62
Dexcom Inc stock is traded at $87.62, with a volume of 2.07M.
It is up +1.34% in the last 24 hours and up +12.29% over the past month.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
See More
Previous Close:
$86.43
Open:
$86.61
24h Volume:
2.07M
Relative Volume:
0.55
Market Cap:
$35.10B
Revenue:
$3.95B
Net Income/Loss:
$680.80M
P/E Ratio:
52.47
EPS:
1.67
Net Cash Flow:
$535.00M
1W Performance:
-0.13%
1M Performance:
+12.29%
6M Performance:
+25.67%
1Y Performance:
-27.49%
1-Day Range:
$86.61
$88.70
1-Week Range:
$86.04
$89.59
52-Week Range:
$62.34
$142.00
Dexcom Inc Stock (DXCM) Company Profile
Name
Dexcom Inc
Sector
Industry
Phone
(858) 200-0200
Address
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Compare DXCM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
87.62 | 35.10B | 3.95B | 680.80M | 535.00M | 1.67 |
|
ABT
Abbott Laboratories
|
128.81 | 223.55B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
103.05 | 152.39B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
390.43 | 149.22B | 21.97B | 3.59B | 3.21B | 9.33 |
|
MDT
Medtronic Plc
|
91.99 | 118.43B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
73.22 | 43.46B | 6.60B | 4.16B | 490.10M | 6.93 |
Dexcom Inc Stock (DXCM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-16-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jul-26-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-26-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-30-24 | Initiated | Redburn Atlantic | Neutral |
| Mar-12-24 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-17-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Mar-29-23 | Initiated | UBS | Buy |
| Jan-26-23 | Initiated | Wolfe Research | Outperform |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-15-22 | Initiated | Bernstein | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-03-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-19-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-07-22 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-18-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-28-21 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Jan-06-21 | Upgrade | UBS | Neutral → Buy |
| Oct-02-20 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| May-27-20 | Reiterated | Piper Sandler | Overweight |
| May-14-20 | Initiated | Wells Fargo | Equal Weight |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Nov-07-19 | Reiterated | Canaccord Genuity | Buy |
| Nov-07-19 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-23-19 | Initiated | Stifel | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Oct-19-18 | Upgrade | Goldman | Sell → Neutral |
| Sep-12-18 | Upgrade | Northland Capital | Under Perform → Market Perform |
| Aug-02-18 | Reiterated | Canaccord Genuity | Buy |
| Jul-02-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-08-18 | Upgrade | JP Morgan | Neutral → Overweight |
| May-11-18 | Initiated | BofA/Merrill | Buy |
| May-03-18 | Reiterated | Canaccord Genuity | Buy |
| Apr-04-18 | Initiated | Goldman | Sell |
| Apr-04-18 | Initiated | Guggenheim | Neutral |
| Mar-23-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-04-18 | Downgrade | Northland Capital | Market Perform → Under Perform |
| Sep-28-17 | Reiterated | Wedbush | Outperform |
View All
Dexcom Inc Stock (DXCM) Latest News
DexCom's Crucial Q4 Report: February 13 Will Reveal Full 2024 Performance - StockTitan
Hantz Financial Services Inc. Purchases 115,184 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Smith Group Asset Management LLC Invests $3.27 Million in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Mount Yale Investment Advisors LLC Takes $713,000 Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
5,842 Shares in DexCom, Inc. (NASDAQ:DXCM) Purchased by Flagship Harbor Advisors LLC - MarketBeat
KBC Group NV Sells 579,068 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Shares Bought by Fifth Third Bancorp - MarketBeat
Commit To Buy DexCom At $50, Earn 8.8% Using Options - Nasdaq
CX Institutional Has $304,000 Stake in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Harrell Investment Partners LLC Trims Stock Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Marshall Financial Group LLC Invests $1.03 Million in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Shares Bought by Janney Montgomery Scott LLC - MarketBeat
DXCM's Preliminary Results Show Strong Growth: How to Play the Stock? - MSN
DexCom raised to outperform by Baird - MSN
Should We Be Delighted With DexCom, Inc.'s (NASDAQ:DXCM) ROE Of 34%? - Yahoo Finance
Gradient Investments LLC Buys 58,947 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Brighton Jones LLC Acquires 11,946 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Nisa Investment Advisors LLC Buys 13,867 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
DexCom Stock Up Following Strong Preliminary Q4 Results & 2025 Outlook - MSN
Teamwork Financial Advisors LLC Purchases 6,221 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Wearable Artificial Organs Global Market Research 2023-2024 & Forecasts to 2034: Government Funding and Initiatives, & Patient Preference for Non-Invasive Solutions Boost Growth - GlobeNewswire Inc.
What to Expect From DexCom's Q4 2024 Earnings Report - MSN
MBM Wealth Consultants LLC Makes New $465,000 Investment in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Shares Purchased by Mitsubishi UFJ Asset Management UK Ltd. - MarketBeat
Raymond James maintains Strong Buy on DexCom with $99 target - MSN
DexCom Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
What To Expect From DexCom's Q4 2024 Earnings Report - Barchart
Park Avenue Securities LLC Raises Stock Holdings in DexCom, Inc. (NASDAQ:DXCM) - Defense World
Wealthcare Advisory Partners LLC Sells 4,265 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Gateway Investment Advisers LLC Reduces Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Short Interest Down 5.7% in December - MarketBeat
Dexcom inks glucose biosensor partnership with Life Time - Drug Delivery Business News
DexCom (NASDAQ:DXCM) shareholder returns have been decent, earning 44% in 5 years - Yahoo Finance
Sax Wealth Advisors LLC Grows Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Avanza Fonder AB Makes New Investment in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Legacy Wealth Asset Management LLC Acquires New Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Baird R W Upgrades DexCom (NASDAQ:DXCM) to “Strong-Buy” - Defense World
DexCom: Fairly Priced In 2025; Why I'm Not Expecting A Share Price Comeback - Seeking Alpha
DexCom, Inc. (NASDAQ:DXCM) Stake Reduced by Woodstock Corp - MarketBeat
DexCom (NASDAQ:DXCM) Stock Price Up 3.7%Here's What Happened - MarketBeat
JPM25 recap: Robotics, PFA and OTC glucose sensors in the spotlight - MedTech Dive
Baird R W Upgrades DexCom (NASDAQ:DXCM) to Strong-Buy - MarketBeat
Latin America Continuous Glucose Monitoring Device Market Projected To Witness Substantial Growth, - EIN News
Fifth Third Wealth Advisors LLC Trims Stock Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Oak Thistle LLC Cuts Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom (NASDAQ:DXCM) Stock Unloaded Rep. Kevin Hern - MarketBeat
DexCom Inc. stock outperforms competitors on strong trading day - MSN
Why DexCom, Inc. (DXCM) Is Skyrocketing - Insider Monkey
DexCom raised to outperform by Baird (DXCM:NASDAQ) - Seeking Alpha
Piper Sandler bullish on DexCom shares citing growth potential and new catalysts - MSN
Dexcom Inc Stock (DXCM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.91%
0.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):